Literature DB >> 33436637

Collective synthesis of acetylenic pharmaceuticals via enantioselective Nickel/Lewis acid-catalyzed propargylic alkylation.

Xihao Chang1, Jiayin Zhang1, Lingzi Peng1, Chang Guo2.   

Abstract

Chiral acetylenic derivatives are found in many bioactive compounds and are versatile functional groups in organic chemistry. Here, we describe an enantioselective nickel/Lewis acid-catalyzed asymmetric propargylic substitution reaction from simple achiral materials under mild condition. The introduction of a Lewis acid cocatalyst is crucial to the efficiency of the transformation. Notably, we investigate this asymmetric propargylic substitution reaction for the development of a range of structurally diverse natural products. The power of this strategy is highlighted by the collective synthesis of seven biologically active compounds: (-)-Thiohexital, (+)-Thiopental, (+)-Pentobarbital, (-)-AMG 837, (+)-Phenoxanol, (+)-Citralis, and (-)-Citralis Nitrile.

Entities:  

Year:  2021        PMID: 33436637     DOI: 10.1038/s41467-020-20644-9

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  27 in total

1.  Palladium-catalyzed asymmetric allylic alkylation of barbituric acid derivatives: enantioselective syntheses of cyclopentobarbital and pentobarbital.

Authors:  B M Trost; G M Schroeder
Journal:  J Org Chem       Date:  2000-03-10       Impact factor: 4.354

Review 2.  Pharmacologically active compounds in the environment and their chirality.

Authors:  Barbara Kasprzyk-Hordern
Journal:  Chem Soc Rev       Date:  2010-09-20       Impact factor: 54.564

Review 3.  The nose as a stereochemist. Enantiomers and odor.

Authors:  Ronald Bentley
Journal:  Chem Rev       Date:  2006-09       Impact factor: 60.622

4.  Collective synthesis of natural products by means of organocascade catalysis.

Authors:  Spencer B Jones; Bryon Simmons; Anthony Mastracchio; David W C MacMillan
Journal:  Nature       Date:  2011-07-13       Impact factor: 49.962

5.  Synthesis and pharmacological activity of thiohexital enantiomers.

Authors:  F I Carroll; A Philip; D M Naylor; H D Christensen; W C Goad
Journal:  J Med Chem       Date:  1981-10       Impact factor: 7.446

6.  Development of Chiral, Bifunctional Thiosquaramides: Enantioselective Michael Additions of Barbituric Acids to Nitroalkenes.

Authors:  Michael Rombola; Chintan S Sumaria; Thomas D Montgomery; Viresh H Rawal
Journal:  J Am Chem Soc       Date:  2017-04-04       Impact factor: 15.419

7.  Catalytic Asymmetric Synthesis of Quaternary Barbituric Acids.

Authors:  Sandra Del Pozo; Silvia Vera; Mikel Oiarbide; Claudio Palomo
Journal:  J Am Chem Soc       Date:  2017-10-17       Impact factor: 15.419

8.  AMG 837: a potent, orally bioavailable GPR40 agonist.

Authors:  Jonathan B Houze; Liusheng Zhu; Ying Sun; Michelle Akerman; Wei Qiu; Alex J Zhang; Rajiv Sharma; Michael Schmitt; Yingcai Wang; Jiwen Liu; Jinqian Liu; Julio C Medina; Jeff D Reagan; Jian Luo; George Tonn; Jane Zhang; Jenny Ying-Lin Lu; Michael Chen; Edwin Lopez; Kathy Nguyen; Li Yang; Liang Tang; Hui Tian; Steven J Shuttleworth; Daniel C-H Lin
Journal:  Bioorg Med Chem Lett       Date:  2011-11-06       Impact factor: 2.940

9.  Chiral drugs: an overview.

Authors:  Lien Ai Nguyen; Hua He; Chuong Pham-Huy
Journal:  Int J Biomed Sci       Date:  2006-06

10.  The history of barbiturates a century after their clinical introduction.

Authors:  Francisco López-Muñoz; Ronaldo Ucha-Udabe; Cecilio Alamo
Journal:  Neuropsychiatr Dis Treat       Date:  2005-12       Impact factor: 2.570

View more
  2 in total

1.  Enantioselective and Diastereodivergent Allylation of Propargylic C-H Bonds.

Authors:  Jin Zhu; Yidong Wang; Aaron D Charlack; Yi-Ming Wang
Journal:  J Am Chem Soc       Date:  2022-08-17       Impact factor: 16.383

2.  Doubly stereoconvergent construction of vicinal all-carbon quaternary and tertiary stereocenters by Cu/Mg-catalyzed propargylic substitution.

Authors:  Xiang Pu; Qiu-Di Dang; Lei Yang; Xia Zhang; Dawen Niu
Journal:  Nat Commun       Date:  2022-05-04       Impact factor: 17.694

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.